The Role of p53 Mutation in Pediatric Bone Marrow Hypoplasia
Author Information
Author(s): Abo-Elwafa Hasnaa A, Attia Fadia M, Sharaf Alzahraa EA
Primary Institution: Sohag University
Hypothesis
DNA damage and cancer predisposition in bone marrow failure disorders could be related to p53 gene alterations.
Conclusion
p53 gene mutation in hypoplastic marrow, especially in Fanconi Anemia, may indicate significant DNA genetic alteration with cancer risk.
Supporting Evidence
- 90% of children with Fanconi Anemia showed p53 mutations.
- Only 10% of children with acquired aplastic anemia had p53 mutations.
- No p53 mutations were found in the control group.
Takeaway
This study looked at kids with bone marrow problems and found that a gene called p53 is often mutated in those with a specific condition called Fanconi Anemia, which might make them more likely to get cancer.
Methodology
The study investigated p53 mutation in the bone marrow and peripheral blood of 40 children using real-time PCR.
Limitations
The small number of patients limits the generalizability of the findings.
Participant Demographics
The study included 40 children: 10 with Fanconi Anemia, 10 with acquired aplastic anemia, and 20 with immune thrombocytopenia, aged 4 to 14 years.
Statistical Information
P-Value
< 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website